Clinical Trial Update: INDICOR The Paclitaxel-Eluting PTCA-Balloon Catheter in Combination With a Cobalt-Chromium Stent [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating the INDICOR paclitaxel-eluting PTCA-balloon catheter in combination with a cobalt-chromium sten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cobalt-Chromium Stent (cobalt-chromium stent)
• INDICOR Paclitaxel-Eluting PTCA-Balloon Catheter (paclitaxel-eluting PTCA-balloon catheter)

Snippet

Sponsor: Ralf Degenhardt, PhD | Conditions: Coronary Heart Diseases | Phase 3 | Status: COMPLETED